Inicio › Enfermedad pulmonar intersticial › Kansas › Kansas City
Ensayos clínicos de Enfermedad pulmonar intersticial en Kansas City, KS
13 estudios para Enfermedad pulmonar intersticial buscan participantes en centros de Kansas City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
ReclutandoFase 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
ReclutandoFase 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutandoFase 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
ReclutandoFase 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
ReclutandoFase 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
ReclutandoEstudio observacional
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
ReclutandoFase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
ReclutandoFase 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
ReclutandoFase 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
ReclutandoFase 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
ReclutandoEstudio observacional
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
ReclutandoFase 1Se aceptan voluntarios sanos
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
ReclutandoEstudio observacional
- University of Kansas, Kansas City
Más información sobre Enfermedad pulmonar intersticial en MedlinePlus
Ensayos de Enfermedad pulmonar intersticial en otras ciudades
- New York City, NY18 estudios
- Philadelphia, PA16 estudios
- Los Angeles, CA14 estudios
- Charleston, SC13 estudios
- Durham, NC13 estudios
- Chicago, IL12 estudios
- Houston, TX12 estudios
- Aurora, CO11 estudios
- Ann Arbor, MI11 estudios
- Salt Lake City, UT9 estudios
- Dallas, TX9 estudios
- Boston, MA9 estudios
Otros estudios en Kansas City
- Enfermedad cardiovascular14 estudios
- Fallo cardíaco13 estudios
- Obesidad13 estudios
- Fibrosis quística13 estudios
- Cáncer de seno12 estudios
- Cáncer de vejiga12 estudios
- Leucemia mielógena aguda12 estudios
- Cáncer de próstata12 estudios
- Cáncer de pulmón de células no pequeñas11 estudios
- Cáncer de pulmón11 estudios
- Enfermedad de obstrucción pulmonar crónica9 estudios
- Asma8 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.